what are glp-1 drugs made from Frontiers PDB-101: Molecule of the Month:

The best results happen when the medicine is used along with healthy eating and exercise, and people may gain weight back if they stop taking the medicine

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as semaglutide and tirzepatide, have emerged as transformative agents for type 2 diabetes and obesity through their potent effects on weight reduction, insulin sensitivity, and cardiovascular outcomes

Learn about the mechanism of action of RYBELSUS (semaglutide) for your adult patients with type 2 diabetes

Beyond these metabolic benefits, accumulating evidence indicates that GLP-1RAs exert immunomodulatory effects, including suppression of pro-inflammatory cytokines, enhancement of regulatory T-cell function, and improvements in adipose tissue and gut-derived immune signaling